NEW YORK (Reuters Health) – For octogenarians undergoing percutaneous coronary intervention, the use of drug-eluting stents is safe and more effective than using bare metal stents, a Dutch…
NEW YORK (Reuters Health) – For patients with significant carotid artery stenosis, undergoing carotid artery stenting (CAS) carries a higher risk of death or stroke than does carotid…
NEW YORK (Reuters Health) – The percentage of cardiac surgery patients given blood transfusions varies widely from center to center, but a conservative use of transfusions is not…
NEW YORK (Reuters Health) – Mortality in acute coronary syndromes is no lower among those taking aspirin before the event than in non-aspirin users. This apparent “aspirin paradox”…
NEW YORK (Reuters Health) – Outcomes in patients with acute MI undergoing percutaneous coronary intervention are better with increasing levels of LDL cholesterol, a Korean group reports. However,…
NEW YORK (Reuters Health) – Compared with unfractionated heparin, bivalirudin used for anticoagulation in unselected patients undergoing percutaneous coronary intervention is associated with less bleeding after 1 month…
NEW YORK (Reuters Health) – The diagnostic accuracy of rotational coronary angiography is as good as that of conventional angiography, but it significantly reduces the amount of radiation…
NEW YORK (Reuters Health) – In recipients of drug-eluting coronary stents who undergo a major noncardiac surgical procedure some months later, the risk of adverse outcomes is less…
NEW YORK (Reuters Health) – Left ventricular thrombus is still quite a frequent finding in patients with an anterior wall MI who have been treated by percutaneous coronary…
NEW YORK (Reuters Health) – Delivery of abciximab directly to the intracoronary thrombus in patients with acute coronary syndromes is more effective than intracoronary bolus infusion in reducing…